Clinical trial
Study of Valproic Acid to Treat HIV Infected Adults
NCT00312546 · University of North Carolina, Chapel Hill, Other · Terminated
Key facts
| NCT number | NCT00312546 |
|---|---|
| Title | Study of Valproic Acid to Treat HIV Infected Adults |
| Official title | Inhibiting Histone Deacetylase: Toward Eradication of HIV |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Enfuvirtide, Valproic acid |
| Enrollment | 14 |
| Start date | Jun 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Apr 10, 2006 |
| Last update posted | May 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: